✨ Your Portfolio is fetched and updated from zerodha.
Small Pharmaceuticals

Caplin Point Laboratories Ltd.

CAPLIPOINT

Get real time AI alerts about this company on your WhatsApp!
Market Cap
₹17,722 Cr.
P/E
31.36

Caplin Point Laboratories Ltd.

  • Caplin Point Lab
  • Gufic Biosciences
  • Gland Pharma
  • TJI Pharma - Small Cap

FAQs on Caplin Point Laboratories Ltd. Shareprice

Caplin Point Lab has given better returns compared to its competitors.
Caplin Point Lab has grown at ~26.78% over the last 4yrs while peers have grown at a median rate of 15.42%

Yes, Caplin Point Lab is expensive.
Latest PE of Caplin Point Lab is 30.2, while 3 year average PE is 22.71.
Also latest EV/EBITDA of Caplin Point Lab is 24.48 while 3yr average is 17.03.

View FAQ's On Business

Growth Table

  • Caplin Point Laboratories Ltd.
  • Gufic Biosciences
  • Gland Pharma

Balance Sheet

  • Caplin Point Laboratories Ltd.
  • Gufic Biosciences
  • Gland Pharma

Balance Sheet Snapshot

No data available.

Fund Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end

Profit & Loss

  • Caplin Point Laboratories Ltd.
  • Gufic Biosciences
  • Gland Pharma

Cash Flow

  • Caplin Point Laboratories Ltd.
  • Gufic Biosciences
  • Gland Pharma

Cash Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.

Ratios

= Dominant Factor
  • Caplin Point Laboratories Ltd.
  • Gufic Biosciences
  • Gland Pharma

Quarterly Results

  • Caplin Point Laboratories Ltd.
  • Gufic Biosciences
  • Gland Pharma

Reverse DCF

locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF

FAQs on Caplin Point Laboratories Ltd. Financials

Balance sheet of Caplin Point Lab is strong.
It shouldn't have solvency or liquidity issues.

The net debt of Caplin Point Lab is decreasing.
Latest net debt of Caplin Point Lab is -₹1,182.05 Crs as of Mar-25.
This is less than Mar-24 when it was -₹1,105.06 Crs.

Yes, profit is increasing.
The profit of Caplin Point Lab is ₹567 Crs for TTM, ₹536 Crs for Mar 2025 and ₹457 Crs for Mar 2024.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Caplin Point Lab latest dividend payout ratio is 8.5% and 3yr average dividend payout ratio is 8.63%

Companies resources are majorly tied in miscellaneous assets

View FAQ's On Shareholding
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech